PDS Biotechnology (PDSB) Research & Development (2014 - 2026)
PDS Biotechnology (PDSB) recorded Research & Development of $3.27 million in Q2 2026, down 22.5% from $4.21 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Research & Development (2014 - 2026) Analysis & Trends
On a TTM basis, PDS Biotechnology's Research & Development came in at $16.46 million as of Jun 30, 2026, down 23.0% year-over-year; for FY2025, it came in at $19.03 million, down 15.7% from FY2024.
- Annual Research & Development has declined for three straight years, though with a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $22.57 million in FY2024 (-18.7%), $27.76 million in FY2023 (-5.7%), $29.43 million in FY2022 (+161.5%) and $11.25 million in FY2021 (+42.0%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q2 2021.
- On a year-over-year basis, Research & Development rose in 1 of the last seven quarters, with an average decline of 16.0%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 376.7% in Q4 2022, against a decline of 53.8% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | PDS Biotechnology | 43.06 Mn | 43.06 Mn | - | 3.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.27 Mn |
| Dec 31, 2025 | 4.41 Mn |
| Sep 30, 2025 | 4.58 Mn |
| Jun 30, 2025 | 4.21 Mn |
| Mar 31, 2025 | 5.83 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 6.80 Mn |
| Jun 30, 2024 | 4.53 Mn |
| Mar 31, 2024 | 6.70 Mn |
| Dec 31, 2023 | 7.47 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 8.00 Mn |
| Mar 31, 2023 | 5.84 Mn |
| Dec 31, 2022 | 16.16 Mn |
| Sep 30, 2022 | 4.35 Mn |
| Jun 30, 2022 | 3.76 Mn |
| Mar 31, 2022 | 5.16 Mn |
| Dec 31, 2021 | 3.39 Mn |
| Sep 30, 2021 | 3.69 Mn |
| Jun 30, 2021 | 2.76 Mn |
API Access
PDS Biotechnology Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();